Trial Profile
Comparative Evaluation of Intraocular Pressure During the 24 Hour in Patients Affected by Primary Open-angle Glaucoma and Ocular Hypertension: Latanoprost 0.005% Versus Tafluprost 0.0015% Ophthalmic Solutions
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Apr 2020
Price :
$35
*
At a glance
- Drugs Tafluprost (Primary) ; Latanoprost
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Acronyms SAF-24H-IOP
- 24 Aug 2015 New trial record